Aug. 4 at 3:23 PM
$IMDX I try not to think too much into this, but I think reiterating 8/10 for the 10-Q is good news. They haven't been to any investor conferences for over a quarter now implicating the "quiet period" before the decision and
$BIO agreement, but now they are the day after earnings... Why would I want to do a 1x1 if there's no news and they can't talk about the FDA timeline? Doesn't make sense, so I'm leaning bullish on the report and imminent approval, on track to 8/20 or even earlier. I'm not buying more before the readout as it's such a frizzy thought, though
